经尿道联合经阴道Smooth模式铒激光照射治疗女性压力性尿失禁的疗效评价

许盛飞; 秦保龙; 杜广辉; 陈忠; 凌青; 蔡丹; 陈江; 李黎娜; 库尔班江·阿不力克木; 袁晓奕

doi:10.13201/j.issn.1001-1420.2021.06.012

经尿道联合经阴道Smooth模式铒激光照射治疗女性压力性尿失禁的疗效评价

- 华中科技大学同济医学院附属同济医院泌尿外科(武汉, 430030)
基金项目:
国家自然科学基金项目(No:81800673)

湖北省卫生和计划生育委员会科研项目(No:WJ2017M089)

详细信息

通讯作者: 袁晓奕,E-mail:yuanxiaoyi@hotmail.com

中图分类号: R694.54

收稿日期: 2020-05-05

Efficacy evaluation of transurethral combined with transvaginal Smooth mode erbium:yttrium-aluminum garnet laser in the treatment of female stress urinary incontinence

- Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

More Information

Corresponding author: YUAN Xiaoyi, E-mail: yuanxiaoyi@hotmail.com

Received Date: 05 May 2020

摘要

摘要: 为了评价经尿道联合经阴道Smooth模式铒激光(Er:YAG)照射治疗女性压力性尿失禁(SUI)的安全性和有效性,本研究选取了2018年10月—2019年9月期间于我院门诊就诊的21例患有轻中度SUI的已婚成年女性。所有患者均在局部麻醉下分3次接受经尿道联合经阴道Smooth模式铒激光照射治疗,每次治疗间隔4周并对治疗前、治疗后1个月和3个月的疗效以及相关不良事件分别进行统计和随访。疗效的统计随访采用国际尿控学会(ICS)标准化1 h尿垫试验(ICS-pad test)和国际尿失禁咨询委员会尿失禁问卷简表(ICIQ-SF),统计学分析采用配对样本t检验。结果显示,治疗后1个月和3个月随访的ICIQ-SF评分和1 h尿垫试验显著下降(P<0.05),术后3个月有效率为81%,治疗后均未出现严重不良反应。提示经尿道联合经阴道Smooth模式铒激光照射治疗方式具有治疗时间短、治疗效果明显的优势,对治疗轻中度女性SUI是安全有效的。
- 铒激光 /
- 压力性尿失禁 /
- 尿道 /
- 阴道
Abstract: In order to evaluate the safety and efficacy of transurethral combined with transvaginal Smooth mode erbium: yttrium-aluminum garnet(Er: YAG) laser in the treatment of female stress urinary incontinence(SUI), 21 adult women with mild to moderate SUI treated during October 2018 and September 2019 were enrolled in this study. All patients received transurethral combined with transvaginal Smooth mode Er: YAG laser treatment for 3 times under local anesthesia, with 4 weeks interval. The results of International Continence Society(ICS) standardized 1-hour urine pad test(ICS-pad test), the International Consultation on Incontinence Questionnaire-Short Form(ICIQ-SF), and adverse events were recorded before, 1 and 3 months after treatment for comparative analysis. Statistical analysis was done using paired sample t test(P<0.05). The results showed that the ICIQ-SF score and 1-hour pad test decreased significantly after 1 and 3 months of treatment. There were no adverse events after treatment. The total effective rate was 81% after 3 months of treatment. The results of the study suggested that transurethral combined with transvaginal Smooth mode Er: YAG laser treatment has the advantages of short treatment time and obvious treatment effect, which is safe and effective for the treatment of mild and moderate female SUI.
- erbium: yttrium-aluminum garnet laser /
- stress urinary incontinence /
- urethra /
- vagina

HTML全文

参考文献(14)

[1]	Kinchen KS,Lee J,Fireman B,et al.The prevalence,burden,and treatment of urinary incontinence among women in a managed care plan[J].J Womens Health(Larchmt),2007,16(3):415-422.
[2]	Markland AD,Richter HE,Fwu CW,et al,Prevalence and trends of urinary incontinence in adults in the United States,2001 to 2008[J].J Urol,2011,186(2):589-593.
[3]	Lin KL,Chou SH,Long CY.Effect of Er:YAG Laser for Women with Stress Urinary Incontinence[J].Biomed Res Int,2019,2019:7915813.
[4]	Gaspar A,Brandi H.Non-ablative erbium YAG laser for the treatment of type Ⅲ stress urinary incontinence(intrinsic sphincter deficiency)[J].Lasers Med Sci,2017,32(3):685-691.
[5]	Fistonic,I,Fistonic N.Baseline ICIQ-UI score,body mass index,age,average birth weight,and perineometry duration as promising predictors of the short-term efficacy of Er:YAG laser treatment in stress urinary incontinent women:A prospective cohort study[J].Lasers Surg Med,2018,50(6):636-643.
[6]	Gambacciani,M,Levancini M,Russo E,et al,Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause[J].Climacteric,2018,21(2):148-152.
[7]	袁晓奕.铒激光技术治疗压力性尿失禁[J].临床外科杂志,2020,28(2):113-115.
[8]	Elia D,Gambacciani M,Berreni N,et al.Genitourinary syndrome of menopause(GSM)and laser VEL:a review[J].Horm Mol Biol Clin Investig,2019.
[9]	Gaspar A,Brandi H,Gomez V,et al.Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause[J].Lasers Surg Med,2017,49(2):160-168.
[10]	Erel CT,Inan D,Mut A,Predictive factors for the efficacy of Er:YAG laser treatment of urinary incontinence[J].Maturitas,2020,132:1-6.
[11]	Drnovsek-Olup B,Beltram BM,Pizem J,Repetitive Er:YAG laser irradiation of human skin:a histological evaluation[J].Lasers Surg Med,2004,35(2):146-151.
[12]	Yamakawa S,Niwa T,Karakida T,et al.Effects of Er:YAG and Diode Laser Irradiation on Dental Pulp Cells and Tissues[J].Int J Mol Sci,2018,19(8):2429.
[13]	El-Domyati M,El-Ammawi TS,Medhat W,et al.Expression of transforming growth factor-β after different non-invasive facial rejuvenation modalities[J].Int J Dermatol,2015,54(4):396-404.
[14]	Bodendorf MO,Willenberg A,Anderegg U,et al.Connective tissue response to fractionated thermo-ablative Erbium:YAG skin laser treatment[J].Int J Cosmet Sci,2010,32(6):435-445.